107 related articles for article (PubMed ID: 16455983)
1. Human mast cells undergo TRAIL-induced apoptosis.
Berent-Maoz B; Piliponsky AM; Daigle I; Simon HU; Levi-Schaffer F
J Immunol; 2006 Feb; 176(4):2272-8. PubMed ID: 16455983
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
Shin EC; Ahn JM; Kim CH; Choi Y; Ahn YS; Kim H; Kim SJ; Park JH
Int J Cancer; 2001 Jul; 93(2):262-8. PubMed ID: 11410875
[TBL] [Abstract][Full Text] [Related]
3. TRAIL mediated signaling in human mast cells: the influence of IgE-dependent activation.
Berent-Maoz B; Salemi S; Mankuta D; Simon HU; Levi-Schaffer F
Allergy; 2008 Mar; 63(3):333-40. PubMed ID: 18269677
[TBL] [Abstract][Full Text] [Related]
4. Human mast cells express intracellular TRAIL.
Berent-Maoz B; Salemi S; Mankuta D; Simon HU; Levi-Schaffer F
Cell Immunol; 2010; 262(2):80-3. PubMed ID: 20189551
[TBL] [Abstract][Full Text] [Related]
5. Cellular IAP1 regulates TRAIL-induced apoptosis in human fetal cortical neural progenitor cells.
Peng H; Huang Y; Duan Z; Erdmann N; Xu D; Herek S; Zheng J
J Neurosci Res; 2005 Nov; 82(3):295-305. PubMed ID: 16180223
[TBL] [Abstract][Full Text] [Related]
6. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
[TBL] [Abstract][Full Text] [Related]
8. Cell Death Inhibiting RNA (CDIR) modulates IFN-gamma-stimulated sensitization to Fas/CD95/Apo-1 and TRAIL/Apo-2L-induced apoptosis.
Shchors K; Yehiely F; Deiss LP
Cell Cycle; 2004 Dec; 3(12):1606-11. PubMed ID: 15611657
[TBL] [Abstract][Full Text] [Related]
9. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
Chaturvedi V; Bodner B; Qin JZ; Nickoloff BJ
J Dermatol Sci; 2006 Jan; 41(1):31-41. PubMed ID: 16289694
[TBL] [Abstract][Full Text] [Related]
10. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424
[TBL] [Abstract][Full Text] [Related]
12. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL).
Robbins MA; Maksumova L; Pocock E; Chantler JK
Endocrinology; 2003 Oct; 144(10):4616-25. PubMed ID: 12960048
[TBL] [Abstract][Full Text] [Related]
14. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway.
Chou AH; Tsai HF; Wu YY; Hu CY; Hwang LH; Hsu PI; Hsu PN
J Immunol; 2005 Feb; 174(4):2160-6. PubMed ID: 15699147
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
[TBL] [Abstract][Full Text] [Related]
18. Reovirus-induced apoptosis is mediated by TRAIL.
Clarke P; Meintzer SM; Gibson S; Widmann C; Garrington TP; Johnson GL; Tyler KL
J Virol; 2000 Sep; 74(17):8135-9. PubMed ID: 10933724
[TBL] [Abstract][Full Text] [Related]
19. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
